Cefpodoxime 200 MG Oral Tablet — RxCUI 309078
RxNorm drug concept · Semantic clinical drug
RxCUI 309078
Semantic clinical drug · SCD
● Current RxNorm concept 18 FDA products
38 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI309078
Official nameCefpodoxime 200 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascefpodoxime proxetil 200 MG Oral Tablet
FDA products mapped18
Package NDCs mapped38
Reported Medicaid activity (SDUD)111,789 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Cefpodoxime: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Cefpodoxime treats a wide range of common bacterial infections. These include ear infections, strep throat and tonsillitis, sinus infections, pneumonia, bronchitis flare-ups, skin...
- What kinds of infections does cefpodoxime treat?
- It depends on which form you have. If you're taking the tablet, take it with food — your body absorbs it better that way, so you'll get more of the medication working for you. If y...
- Should I take cefpodoxime with food or on an empty stomach?
🕸️ Concept Web — How Cefpodoxime 200 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Cefpodoxime 200 MG Oral Tablet
RxCUI 309078 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Cefpodoxime
20489IN
-
Cefpodoxime
-
Brand names 3
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Cefpoderm
2110498BN -
Dermaceph
2727382BN -
Simplicef
892779BN
-
Cefpoderm
-
Dose forms 15
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Cefpodoxime Oral Tablet
371334SCDF -
Cefpodoxime Oral Product
1161214SCDG -
Cefpodoxime Pill
1161215SCDG -
Cefpodoxime Oral Tablet [Cefpoderm]
2110500SBDF -
Cefpodoxime Oral Tablet [Dermaceph]
2727386SBDF -
Cefpodoxime Oral Tablet [Simplicef]
892781SBDF -
Cefpoderm Oral Product
2110501SBDG -
Cefpoderm Pill
2110502SBDG - +7 more in this family
-
Cefpodoxime Oral Tablet
-
Clinical & branded drugs 7
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Cefpodoxime 200 MG
329658SCDC -
Cefpodoxime 200 MG Oral Tablet [Cefpoderm]
2110505SBD -
Cefpodoxime 200 MG Oral Tablet [Dermaceph]
2727389SBD -
Cefpodoxime 200 MG Oral Tablet [Simplicef]
892784SBD -
Cefpodoxime 200 MG [Cefpoderm]
2110504SBDC -
Cefpodoxime 200 MG [Dermaceph]
2727388SBDC -
Cefpodoxime 200 MG [Simplicef]
892783SBDC
-
Cefpodoxime 200 MG
Showing up to 8 concepts per family — 19 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Cefpodoxime 200 MG
SCDC · 329658 -
Cefpodoxime Oral Tablet
SCDF · 371334 -
Cefpodoxime Oral Product
SCDG · 1161214 -
Cefpodoxime Pill
SCDG · 1161215
Brand-Name Concepts
-
Cefpodoxime 200 MG Oral Tablet [Cefpoderm]
SBD · 2110505 -
Cefpodoxime 200 MG Oral Tablet [Dermaceph]
SBD · 2727389 -
Cefpodoxime 200 MG Oral Tablet [Simplicef]
SBD · 892784 -
Cefpodoxime 200 MG [Cefpoderm]
SBDC · 2110504 -
Cefpodoxime 200 MG [Dermaceph]
SBDC · 2727388 -
Cefpodoxime 200 MG [Simplicef]
SBDC · 892783 -
Cefpodoxime Oral Tablet [Cefpoderm]
SBDF · 2110500 -
Cefpodoxime Oral Tablet [Dermaceph]
SBDF · 2727386 -
Cefpodoxime Oral Tablet [Simplicef]
SBDF · 892781 -
Cefpoderm Oral Product
SBDG · 2110501
📦 FDA Products & Package NDCs
18 products · 38 package NDCs
38 package NDCs map to RxCUI 309078 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00781-5438-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0781-5438-01) | Cefpodoxime Proxetil | Sandoz Inc | 2008-05-28 |
| 00781-5438-20 | 20 TABLET, FILM COATED in 1 BOTTLE (0781-5438-20) | Cefpodoxime Proxetil | Sandoz Inc | 2008-05-28 |
| 00781-5439-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0781-5439-01) | Cefpodoxime Proxetil | Sandoz Inc | 2008-05-28 |
| 00781-5439-20 | 20 TABLET, FILM COATED in 1 BOTTLE (0781-5439-20) | Cefpodoxime Proxetil | Sandoz Inc | 2008-05-28 |
| 16714-0394-01 | 20 TABLET, FILM COATED in 1 BOTTLE (16714-394-01) | CEFPODOXIME PROXETIL | NorthStar Rx LLC | 2007-06-11 |
| 16714-0395-01 | 20 TABLET, FILM COATED in 1 BOTTLE (16714-395-01) | CEFPODOXIME PROXETIL | NorthStar Rx LLC | 2007-06-11 |
| 51407-0083-20 | 20 TABLET, FILM COATED in 1 BOTTLE (51407-083-20) | Cefpodoxime Proxetil | Golden State Medical Supply, Inc. | 2023-04-03 |
| 51407-0084-20 | 20 TABLET, FILM COATED in 1 BOTTLE (51407-084-20) | Cefpodoxime Proxetil | Golden State Medical Supply, Inc. | 2023-04-03 |
| 65862-0095-01 | 100 TABLET, FILM COATED in 1 BOTTLE (65862-095-01) | CEFPODOXIME PROXETIL | Aurobindo Pharma Limited | 2007-06-11 |
| 65862-0095-20 | 20 TABLET, FILM COATED in 1 BOTTLE (65862-095-20) | CEFPODOXIME PROXETIL | Aurobindo Pharma Limited | 2007-06-11 |
| 65862-0095-25 | 250 TABLET, FILM COATED in 1 BOTTLE (65862-095-25) | CEFPODOXIME PROXETIL | Aurobindo Pharma Limited | 2023-10-06 |
| 65862-0095-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (65862-095-99) | CEFPODOXIME PROXETIL | Aurobindo Pharma Limited | 2007-06-11 |
| 65862-0096-01 | 100 TABLET, FILM COATED in 1 BOTTLE (65862-096-01) | CEFPODOXIME PROXETIL | Aurobindo Pharma Limited | 2007-06-11 |
| 65862-0096-20 | 20 TABLET, FILM COATED in 1 BOTTLE (65862-096-20) | CEFPODOXIME PROXETIL | Aurobindo Pharma Limited | 2007-06-11 |
| 65862-0096-25 | 250 TABLET, FILM COATED in 1 BOTTLE (65862-096-25) | CEFPODOXIME PROXETIL | Aurobindo Pharma Limited | 2023-10-06 |
| 65862-0096-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (65862-096-99) | CEFPODOXIME PROXETIL | Aurobindo Pharma Limited | 2007-06-11 |
| 67877-0559-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-559-01) | Cefpodoxime Proxetil | Ascend Laboratories, LLC | 2022-05-19 |
| 67877-0559-05 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-559-05) | Cefpodoxime Proxetil | Ascend Laboratories, LLC | 2022-05-19 |
| 67877-0559-20 | 20 TABLET, FILM COATED in 1 BOTTLE (67877-559-20) | Cefpodoxime Proxetil | Ascend Laboratories, LLC | 2022-05-19 |
| 67877-0560-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-560-01) | Cefpodoxime Proxetil | Ascend Laboratories, LLC | 2022-05-19 |
| 67877-0560-05 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-560-05) | Cefpodoxime Proxetil | Ascend Laboratories, LLC | 2022-05-19 |
| 67877-0560-20 | 20 TABLET, FILM COATED in 1 BOTTLE (67877-560-20) | Cefpodoxime Proxetil | Ascend Laboratories, LLC | 2022-05-19 |
| 67877-0878-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-878-01) | Cefpodoxime Proxetil | Ascend Laboratories, LLC | 2023-03-01 |
| 67877-0878-05 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-878-05) | Cefpodoxime Proxetil | Ascend Laboratories, LLC | 2023-03-01 |
| 67877-0878-20 | 20 TABLET, FILM COATED in 1 BOTTLE (67877-878-20) | Cefpodoxime Proxetil | Ascend Laboratories, LLC | 2023-03-01 |
| 67877-0879-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67877-879-01) | Cefpodoxime Proxetil | Ascend Laboratories, LLC | 2023-03-01 |
| 67877-0879-05 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-879-05) | Cefpodoxime Proxetil | Ascend Laboratories, LLC | 2023-03-01 |
| 67877-0879-20 | 20 TABLET, FILM COATED in 1 BOTTLE (67877-879-20) | Cefpodoxime Proxetil | Ascend Laboratories, LLC | 2023-02-13 |
| 68071-3441-02 | 20 TABLET, FILM COATED in 1 BOTTLE (68071-3441-2) | Cefpodoxime Proxetil | NuCare Pharmaceuticals,Inc. | 2023-06-19 |
| 69043-0006-01 | 100 TABLET, FILM COATED in 1 BOTTLE (69043-006-01) | CEFPODOXIME PROXETIL | Cronus Pharma LLC | 2007-06-11 |
| 69043-0006-25 | 250 TABLET, FILM COATED in 1 BOTTLE (69043-006-25) | CEFPODOXIME PROXETIL | Cronus Pharma LLC | 2023-10-06 |
| 69043-0007-01 | 100 TABLET, FILM COATED in 1 BOTTLE (69043-007-01) | CEFPODOXIME PROXETIL | Cronus Pharma LLC | 2007-06-11 |
| 69043-0007-25 | 250 TABLET, FILM COATED in 1 BOTTLE (69043-007-25) | CEFPODOXIME PROXETIL | Cronus Pharma LLC | 2023-10-06 |
| 69292-0514-01 | 100 TABLET, FILM COATED in 1 BOTTLE (69292-514-01) | Cefpodoxime Proxetil | Amici Pharmaceuticals, LLC. | 2022-12-21 |
| 69292-0514-50 | 500 TABLET, FILM COATED in 1 BOTTLE (69292-514-50) | Cefpodoxime Proxetil | Amici Pharmaceuticals, LLC. | 2022-12-21 |
| 69292-0516-01 | 100 TABLET, FILM COATED in 1 BOTTLE (69292-516-01) | Cefpodoxime Proxetil | Amici Pharmaceuticals, LLC. | 2022-12-21 |
| 69292-0516-50 | 500 TABLET, FILM COATED in 1 BOTTLE (69292-516-50) | Cefpodoxime Proxetil | Amici Pharmaceuticals, LLC. | 2022-12-21 |
| 70518-4676-00 | 50 POUCH in 1 BOX (70518-4676-0) / 1 TABLET, FILM COATED in... | Cefpodoxime Proxetil | REMEDYREPACK INC. | 2026-06-04 |
Observed labelers:
Ascend Laboratories, LLC (12) ·
Aurobindo Pharma Limited (8) ·
Amici Pharmaceuticals, LLC. (4) ·
Cronus Pharma LLC (4) ·
Sandoz Inc (4) ·
Golden State Medical Supply, Inc. (2)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.